수술 중 신경 모니터링(IONM) 시장 규모, 점유율, 동향 및 예측 : 제품 및 서비스별, 출처별, 용도별, 최종사용자별, 지역별(2026-2034년)

The global intraoperative neuromonitoring (IONM) market size was valued at USD 4.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.6 Billion by 2034, exhibiting a CAGR of 5.65% from 2026-2034. North America currently dominates the market, holding a market share of 40% in 2025. The region benefits from highly developed healthcare infrastructure, high surgical procedure volumes, strong reimbursement frameworks, and the presence of major IONM technology providers in the region, all expanding the intraoperative neuromonitoring (IONM) market share.

The market is currently experiencing a steady rise in the global market due to the growing focus on patient safety during complex surgical procedures. The rising number of cases of chronic neurovascular disorders such as epilepsy, stroke, Parkinson's disease, and Alzheimer's disease is compelling the global healthcare industry to adopt the most advanced intraoperative neuromonitoring solutions. The growing demand for minimally invasive and non-invasive surgical procedures is also contributing to the rising demand for intraoperative neuromonitoring solutions, as surgeons require real-time neural feedback to avoid neurological deficits during complex surgical procedures. The increasing expenditure on advanced healthcare services, government initiatives, and increasing reimbursement policies are also promoting the adoption of intraoperative neuromonitoring solutions and services, and the increasing geriatric population prone to neurological disorders is further supporting the intraoperative neuromonitoring (IONM) market growth.

The United States has turned out to be a prominent region in the intraoperative neuromonitoring market because of several factors. The established healthcare infrastructure of the country, combined with the high number of surgical procedures performed in the neurosurgery, spinal, and orthopedic fields, leads to a strong demand for advanced intraoperative neuromonitoring solutions. The favorable reimbursement scenario, which encourages the use of intraoperative neuromonitoring solutions in all major categories of payers, further fuels the demand. The high incidence of neurological disorders is a particularly important point to consider. A study published in JAMA Neurology in 2025 estimated that conditions that affect the nervous system affected 180.3 million people in the United States, making it the leading cause of disability in the United States. Additionally, the intraoperative neuromonitoring (IONM) market outlook in the US is bolstered by continuous technological innovation, strong R&D investment, and a well-trained workforce of certified neurophysiologists, all contributing to sustained market leadership.

INTRAOPERATIVE NEUROMONITORING (IONM) MARKET TRENDS:

Rising Integration of AI and Machine Learning (ML)

One of the most revolutionary trends that is currently transforming the intraoperative neuromonitoring (IONM) industry is the swift adoption of artificial intelligence and machine learning technology in neuromonitoring systems. AI-based solutions are increasingly being used for the analysis of neurophysiological signals in real-time, allowing surgeons to gain predictive results in complex surgeries that would be impossible to interpret manually. The use of AI-based solutions is revolutionizing the accuracy and reliability of neuromonitoring in spinal, vascular, and neurosurgery by using data-driven algorithms that can identify minute changes in signals and predict the risk of nerve injury before it occurs. One of the most important developments in this area is the meta-analysis conducted by Davids Joseph et al. in January 2026, which revealed that AI-assisted IONM had a sensitivity effect size of 75.7% and AUC of 84.9% in glioma surgery, which was significantly more accurate in the evaluation of the functional brain area. The use of AI is simultaneously streamlining interpretation of large intraoperative datasets, reducing reliance on human judgment for pattern recognition, and improving overall patient safety. As AI systems become more accessible and validated across a broader range of surgical applications, their integration into IONM platforms is expected to accelerate substantially in the coming years, reshaping competitive dynamics and the intraoperative neuromonitoring (IONM) market forecast.

Growing Shift Toward Outsourced Monitoring Services

One of the most prominent structural trends observed in the intraoperative neuromonitoring (IONM) market is the increasing trend of outsourcing neuromonitoring services due to the increasing shortage of certified neurophysiologists and the economic benefits of third-party service delivery models. Outsourced IONM companies allow hospitals and ambulatory surgical centers to benefit from the expertise of certified neurophysiologists without having to hire full-time in-house neurophysiologists, making it an attractive option for community hospitals and ambulatory surgical centers. The outsourced market is expanding at a faster rate than the insourced market due to the increasing need for cost-effective solutions in the healthcare industry without compromising the quality of neuromonitoring. In March 2025, the International Society of Intraoperative Neurophysiology and EUROSPINE have launched a specific IONM data collection form within the Spine Tango registry, an effort to standardize the documentation of neuromonitoring and enhance data quality in outsourced and insourced centers.

Increasing Demand from Spinal Surgeries

The rising frequency and complexity of spinal surgical procedures globally represents one of the most powerful demand drivers for the intraoperative neuromonitoring (IONM) market trends. Inherently risky spinal surgeries such as deformity correction, spinal fusion, cervical decompression, and lumbar discectomy, due to the potential for iatrogenic neurological injury, necessitate the use of real-time neuromonitoring. The rising prevalence of the geriatric population, in addition to the increasing incidence of degenerative spinal disorders, trauma, and scoliosis, is fueling the volume of spinal surgeries that require continuous monitoring of the neural pathway. Based on a 2025 publication in the North American Spine Society Journal, there were approximately 700,000 to 900,000 procedures in the United States alone that utilized IONM services in 2024, of which 65% to 70% were for spinal or spinal-related procedures. The high usage rate is a testament to the current standard of care in spinal surgery, where the use of IONM is a crucial component that offers real-time feedback regarding somatosensory evoked potentials, motor evoked potentials, and electromyography values. The steady increase in the volume of spinal surgeries, fueled by demographic shifts and the expanding role of surgery, places the spinal application market segment at the forefront of revenue generation in the developed and developing healthcare infrastructure.

INTRAOPERATIVE NEUROMONITORING (IONM) INDUSTRY SEGMENTATION:

Analysis by Product and Services:

• Systems
• Accessories
• Services

Systems hold 46% of the market share. IONM systems encompass the core hardware and software platforms deployed in operating rooms to capture, process, and interpret real-time neurophysiological signals during surgical procedures. These systems integrate multiple monitoring modalities, including electroencephalography, electromyography, somatosensory evoked potentials, and motor evoked potentials, into unified platforms that deliver actionable feedback to surgical teams. The strong market dominance of systems reflects their central role in enabling the entire IONM workflow; without the underlying system architecture, neither accessories nor services can function effectively. Hospitals and surgical centers typically commit significant capital expenditure to system procurement, given the long operational lifecycle and the safety-critical nature of the technology. Continuous technological evolution, including the development of multimodal platforms with AI-assisted signal interpretation and wireless connectivity, is enhancing system capabilities and broadening their adoption across diverse surgical specialties.

Analysis by Source Type:

• Insourced Monitoring
• Outsourced Monitoring

Insourced monitoring leads the market with a share of 70%. Insourced IONM refers to monitoring services conducted entirely by a hospital's own employed or contracted neurophysiology staff, providing institutions with direct control over personnel qualifications, protocol adherence, and real-time communication between the monitoring team and the surgical staff. Large academic medical centers and high-volume tertiary care hospitals typically prefer insourced models due to the ability to maintain consistent quality standards and to customize monitoring approaches for complex case types. These institutions often have the patient volumes and financial scale necessary to justify dedicated neurophysiology staffing. However, the insourced segment faces increasing pressure from a shortage of certified specialists, which is contributing to growing interest in outsourced alternatives. Despite this dynamic, insourced monitoring continues to dominate because of the high procedural volumes at major hospital systems and the institutional preference for direct oversight. The segment's leadership is further reinforced by the integration of IONM into hospital quality and safety protocols, with many health networks embedding insourced neurophysiology as a standard component of high-acuity surgical care delivery and risk management frameworks.

Analysis by Application:

• Spinal Surgery
• Neurosurgery
• Vascular Surgery
• ENT Surgery
• Orthopedic Surgery
• Others

Spinal surgery dominates the market, with a share of 34%. Spinal surgeries are among the most neurologically sensitive surgical procedures, requiring continuous monitoring of the spinal cord, nerve roots, and peripheral neural structures throughout the operation to prevent postoperative neurological deficits such as paralysis, weakness, or sensory loss. The application of IONM in spinal surgery is now widely established as a standard of care in high-risk procedures including complex spinal deformity correction, instrumented spinal fusions, tumor resections, and cervical spine operations. The high prevalence of degenerative spinal conditions globally, combined with the expanding geriatric population, is driving steady growth in the volume of spinal procedures. The application segment is further supported by ongoing standardization efforts, improved guidelines for IONM use during spinal procedures, and growing evidence demonstrating the clinical and economic benefits of neuromonitoring in reducing surgical complications and improving patient outcomes.

Analysis by End User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Hospitals represent the leading segment, with a market share of 77%. Hospitals serve as the dominant end-user segment within the IONM market due to their capacity to perform a wide range of high-complexity surgical procedures that necessitate comprehensive neuromonitoring services. The scale and diversity of surgical activity within hospital settings, spanning neurosurgery, spinal surgery, cardiothoracic procedures, ENT operations, and orthopedic interventions, creates consistent, high-volume demand for both IONM systems and monitoring services. Major teaching hospitals and tertiary care centers are also the primary adopters of the most advanced multimodal monitoring platforms, including AI-integrated systems and wireless monitoring solutions. Hospitals benefit from established reimbursement pathways for IONM services, particularly in the United States, which facilitates ongoing investment in technology upgrades. As hospitals continue to expand surgical capacity and invest in precision medicine infrastructure, the segment is expected to retain its dominant position throughout the forecast period, even as ambulatory surgical centers progressively capture a growing share of the outpatient surgical market.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

America, accounting for 40% of the share, enjoys the leading position in the market. The region's dominance is underpinned by the United States' highly developed healthcare infrastructure, which supports the highest concentration of certified neurophysiologists, IONM technology providers, and high-volume surgical centers globally. Favorable reimbursement policies from both public and private payers create a financially supportive environment for IONM adoption across surgical specialties. Canada contributes meaningfully to the regional market through its federally supported healthcare system and growing investment in advanced surgical technologies. The region also benefits from active research and development activity, with leading device manufacturers and specialty IONM service firms based predominantly in North America, driving continuous innovation in monitoring platforms, electrode technologies, and remote neurophysiology services that reinforce the region's competitive advantage and long-term market leadership across the IONM landscape.

KEY REGIONAL TAKEAWAYS:

United States Intraoperative Neuromonitoring (IONM) Market Analysis

The United States holds a commanding position in the North America intraoperative neuromonitoring (IONM) market and continues to serve as the global benchmark for IONM technology adoption and clinical practice standards. The country's unique combination of high surgical procedure volumes, well-developed reimbursement infrastructure, and a deeply embedded culture of evidence-based patient safety drives demand for neuromonitoring across all major surgical specialties. US healthcare institutions, from large academic medical centers to community hospitals, have increasingly integrated IONM as a standard component of neurologically sensitive surgical protocols, particularly for spinal deformity correction, neurosurgery, and vascular procedures. The continued aging of the US population, combined with rising rates of diabetes-related neuropathy and neurodegenerative diseases, is expected to sustain long-term growth in demand. The active presence of leading IONM companies, combined with the strength of Medicare and private payer coverage frameworks, positions the US market for continued robust expansion. In 2024, Soterix Medical Inc., the worldwide leader in stimulation and integrated monitoring technologies, today announced it has obtained 510(k) clearance from the U.S. Food & Drug Administration for its MEGA-IOM Intraoperative Neurophysiologic Monitoring (IOM) system. The system offers unparalleled integrated management of central and peripheral nervous systems to minimize postoperative risk and enhance surgical results.

Europe Intraoperative Neuromonitoring (IONM) Market Analysis

Europe represents the second-largest regional market for intraoperative neuromonitoring, driven by the continent's aging demographic profile, high burden of neurological and spinal conditions, and a mature healthcare infrastructure that increasingly prioritizes surgical safety and patient outcomes. Countries such as Germany, France, and the United Kingdom are at the forefront of IONM adoption, supported by national healthcare systems that cover neuromonitoring services for a range of complex surgical procedures. The European regulatory landscape, shaped by the Medical Device Regulation framework with transitional deadlines extended through 2028, provides an evolving but clear pathway for advanced IONM technologies, giving device manufacturers adequate runway for compliance while sustaining market activity. This initiative is expected to accelerate the evidence base supporting broader IONM adoption. The expansion of ambulatory surgical centers, combined with growing medical tourism and increasing healthcare investment in Eastern Europe, further broadens the addressable market across the continent. In 2025, Smith+Nephew (LSE:SN, NYSE:SNN), the international medical technology firm, today reveals a strategic collaboration with Standard Health www.standardhealth.co.uk to aid in the establishment of the UK's inaugural Orthopaedic Ambulatory Surgery Centre. Located in Poole, Dorset, the new facility will provide NHS and private patients access to advanced joint repair and replacement technologies for conditions like rotator cuff repair, ACL reconstruction, knee and hip replacements, and procedures for the foot & ankle/hand & wrist.

Asia-Pacific Intraoperative Neuromonitoring (IONM) Market Analysis

Asia-Pacific represents the fastest-growing regional market for intraoperative neuromonitoring, underpinned by expanding healthcare infrastructure, rising surgical volumes, and increasing awareness of patient safety standards across major economies. China and Japan are the dominant contributors to regional revenues, with India and South Korea emerging as high-growth markets. Japan's aging population and government support for AI-driven medical technology adoption position the country as a key innovator in the IONM space, where platforms are being deployed to offset shortages in neurophysiology specialists. In China, Chinese Census data indicates the elderly population, a primary demographic requiring neurological and spinal surgeries, is expected to surpass 400 million by 2033, directly driving long-term demand for IONM services. Government initiatives to modernize hospital infrastructure and expand surgical capabilities across the region, combined with growing medical tourism activity in India and Southeast Asia, are broadening the addressable market significantly and presenting substantial opportunities for global IONM technology providers.

Latin America Intraoperative Neuromonitoring (IONM) Market Analysis

Latin America is an emerging market for intraoperative neuromonitoring, characterized by growing awareness of surgical patient safety, expanding healthcare infrastructure investment, and a rising volume of complex neurological and spinal surgeries in urban centers. Brazil and Mexico serve as the primary drivers of regional demand, supported by private hospital networks that are increasingly adopting advanced monitoring technologies to align with international surgical safety standards. Governments across the region are investing in healthcare modernization efforts aimed at improving surgical outcomes and reducing postoperative complications, creating a favorable regulatory environment for IONM adoption. While reimbursement frameworks remain less developed compared to North America and Europe, growing private insurance penetration is progressively improving the financial viability of IONM utilization across the region's major surgical facilities.

Middle East and Africa Intraoperative Neuromonitoring (IONM) Market Analysis

The Middle East and Africa represent an early-stage but progressively developing market for intraoperative neuromonitoring, driven by healthcare modernization initiatives, rising surgical capabilities in urban centers, and growing awareness of advanced monitoring technologies. Gulf Cooperation Council countries, particularly Saudi Arabia and the United Arab Emirates, are leading adoption within the region, supported by government-funded healthcare transformation programs that prioritize advanced surgical technologies and patient safety standards. Saudi Arabia's Vision 2030 healthcare reform agenda includes substantial investment in hospital infrastructure and advanced surgical capacity, creating a supportive environment for IONM technology introduction. South Africa is the primary contributor on the African continent, with urban private hospitals driving initial adoption. Across the broader region, the growth trajectory is supported by an expanding young population requiring surgical care, increasing medical tourism, and growing partnerships with international healthcare providers offering training and technology transfer for IONM implementation.

COMPETITIVE LANDSCAPE:

The global intraoperative neuromonitoring (IONM) market is characterized by a dynamic competitive landscape featuring a combination of established medical device manufacturers, specialized IONM service providers, and emerging technology companies. Leading players compete across multiple dimensions including product innovation, service quality, geographic expansion, and strategic partnerships. The market is witnessing intensified consolidation activity as larger organizations seek to acquire niche electrode, signal processing, and AI-driven software expertise. Companies are also investing heavily in AI and remote monitoring capabilities to differentiate their offerings. Outsourced service providers are expanding their remote neurophysiology platforms to serve smaller hospitals and ambulatory surgical centers that lack in-house neurophysiology teams. Mid-size entrants are leveraging cloud-based dashboards to reach rural surgical facilities previously inaccessible, while start-ups focused on brain-computer interface applications attract venture capital, intensifying innovation at the emerging technology frontier of the market.

The report provides a comprehensive analysis of the competitive landscape in the intraoperative neuromonitoring (IONM) market with detailed profiles of all major companies, including:

• Accurate Monitoring
• Computational Diagnostics Inc.
• inomed Medizintechnik GmbH
• IntraNerve Neuroscience Holdings, LLC
• Natus Medical Incorporated
• Neurophysiology Services Asia
• Nihon Kohden Corporation
• NuVasive Inc.
• Specialtycare
• Technomed

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the intraoperative neuromonitoring (IONM) market?

2. What is the future outlook of the intraoperative neuromonitoring (IONM) market?

3. What are the key factors driving the intraoperative neuromonitoring (IONM) market?

4. Which region accounts for the largest intraoperative neuromonitoring (IONM) market share?

5. Which are the leading companies in the global intraoperative neuromonitoring (IONM) market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Intraoperative Neuromonitoring (IONM) Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product and Services

• 6.1 Systems
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Accessories
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Source Type

• 7.1 Insourced Monitoring
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Outsourced Monitoring
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Spinal Surgery
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Neurosurgery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Vascular Surgery
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 ENT Surgery
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Orthopedic Surgery
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers (ASCs)
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Accurate Monitoring
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Computational Diagnostics Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 inomed Medizintechnik GmbH
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 IntraNerve Neuroscience Holdings, LLC
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Natus Medical Incorporated
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Neurophysiology Services Asia
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Nihon Kohden Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 NuVasive Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Specialtycare
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Technomed
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio